Cargando…
Dexmedetomidine sedation in ICU
Dexmedetomidine (DEX), a highly selective α(2)-adrenergic receptor agonist, is the newest agent introduced for sedation in intensive care unit (ICU). The sedation strategy for critically ill patients has stressed light sedation with daily awakening and assessment for neurologic, cognitive, and respi...
Autor principal: | Yu, Soo-Bong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Anesthesiologists
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366305/ https://www.ncbi.nlm.nih.gov/pubmed/22679535 http://dx.doi.org/10.4097/kjae.2012.62.5.405 |
Ejemplares similares
-
Dexmedetomidine for sedation in the medical ICU
por: Venn, RM, et al.
Publicado: (2000) -
Dexmedetomidine: Toward a paradigm shift in ICU sedation
por: Myatra, SN
Publicado: (2014) -
Comparison of sedation with dexmedetomidine versus lorazepam in septic ICU patients
por: Pandharipande, P, et al.
Publicado: (2008) -
Evaluation of Sedation Outcomes Following Increased Dexmedetomidine Use in the ICU
por: Schuler, Brian R., et al.
Publicado: (2020) -
Comparison of post-operative ICU sedation between dexmedetomidine and propofol in Indian population
por: Shah, Prerana N, et al.
Publicado: (2014)